Interactive Blog

One engine, promising drugs for many diseases

March 15, 2022

•

10 minute read

We used our engine to test tens of thousands of drugs for their ability to induce therapeutic immune cell behaviors and validated them in follow-up experiments – surfacing promising therapies for multiple age-related diseases. This approach can be used by our partners in a broad range of therapeutic areas.

Dive into these results in an interactive blog post

At Spring, we've dedicated ourselves to building a technology engine that helps those searching for therapies for many different diseases. This engine is capable of generating strong conviction in screening hits using complex, data-rich assays across thousands of drugs in a broad range of therapeutic areas.

One such therapeutic area that we've extensively validated is immune aging-related diseases. Explore our interactive blog post to learn more.

AUTHORS
Charlie Marsh, Ben Komalo, Brandon White, Ben Kamens, 

Matt Booty, Christian Elabd

THANK YOU

Spring’s AI R&D platform has been acquired by a major biotech leader in the Bay Area.

Read more →


Thank you to our trusted partners across biotech, pharma, and academic research.

Our scientific resources are still available here →

© 2025 Spring Discovery.

All rights reserved.

THANK YOU

Spring’s AI R&D platform has been acquired by a major biotech leader in the Bay Area.

Read more →


Thank you to our trusted partners across biotech, pharma, and academic research.

Our scientific resources are still available here →

© 2025 Spring Discovery.

All rights reserved.

THANK YOU

Spring’s AI R&D platform has been acquired by a major biotech leader in the Bay Area.

Read more →


Thank you to our trusted partners across biotech, pharma, and academic research.

Our scientific resources are still available here →

© 2025 Spring Discovery.

All rights reserved.